Treatment of Insomnia in Migraineurs With Eszopiclone (Lunesta) and Its Effect on Sleep Time, Headache Frequency, and Daytime Functioning: a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study.

Trial Profile

Treatment of Insomnia in Migraineurs With Eszopiclone (Lunesta) and Its Effect on Sleep Time, Headache Frequency, and Daytime Functioning: a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2013

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Insomnia; Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2013 Results presented at the 2013 International Headache Congress .
    • 29 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top